StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: biotech, healthcare · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | ABBV AbbVie | $217.72 | -0.42% | $384.7B | 105.8 | 6.1 | +9.5% | 72.0% | 61 |
| 1 | GILD Gilead Sciences | $134.43 | -1.31% | $166.9B | 18.1 | 5.6 | +3.5% | 79.3% | 66 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $336.79 |
| +0.09% |
| $181.8B |
| 23.3 |
| 4.9 |
| +9.1% |
| 74.0% |
| 53 |
| 3 | REGN Regeneron | $614.78 | -1.08% | $64.5B | 14.6 | 4.3 | +5.9% | 85.7% | 51 |
| 4 | ALNY Alnylam Pharmaceuticals | $301.98 | -1.01% | $40.3B | 69.8 | 9.4 | +82.6% | 80.8% | 49 |
| 5 | VRTX Vertex Pharma | $447.54 | -0.10% | $114.6B | 26.4 | 9.4 | +10.1% | 86.2% | 43 |
| 6 | 950160.KQ 950160.KQ | — | — | — | — | — | — | — | — |
| 7 | 950220.KQ 950220.KQ | — | — | — | — | — | — | — | — |
| 8 | 950200.KQ 950200.KQ | — | — | — | — | — | — | — | — |
| 9 | RVMD RVMD | $157.48 | +1.84% | $33.5B | — | 2893.2 | — | — | — |